Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ShuYangMinNing in Chronic Spontaneous Urticaria
NCT06250400Phase 4Not yet recruiting
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical Inc.
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of histaglobulin in chronic spontaneous urticaria (CSU), sponsored by Hangzhou Grand Biologic Pharmaceutical Inc.. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
histaglobulin
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT06250400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06250400.